Biofrontera Inc. (BFRI)
(Delayed Data from NSDQ)
$1.28 USD
0.00 (0.00%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.28 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Income Statements
Fiscal Year end for Biofrontera Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 34 | 29 | 24 | 19 | NA |
Cost Of Goods | 17 | 15 | 13 | 9 | NA |
Gross Profit | 17 | 13 | 11 | 10 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 39 | 32 | 37 | 19 | 0 |
Income After Depreciation & Amortization | -23 | -19 | -25 | -10 | 0 |
Non-Operating Income | -12 | 18 | -12 | 2 | NA |
Interest Expense | 0 | 0 | 0 | 3 | NA |
Pretax Income | -20 | -1 | -38 | -11 | NA |
Income Taxes | 0 | 0 | 0 | 0 | NA |
Minority Interest | 0 | 0 | 0 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | -20 | -1 | -38 | -11 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | -20 | -1 | -38 | -11 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -22 | -17 | -25 | -9 | 0 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | 1 | NA |
Income After Depreciation & Amortization | -23 | -19 | -25 | -10 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 1.55 | 1.06 | 0.44 | NA | NA |
Diluted EPS Before Non-Recurring Items | -16.60 | -18.80 | -59.80 | NA | NA |
Diluted Net EPS (GAAP) | -13.02 | -0.60 | -85.60 | NA | NA |
Fiscal Year end for Biofrontera Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 7.84 | 7.91 | 10.59 | 8.90 | 5.85 |
Cost Of Goods | 4.34 | 4.12 | 5.37 | 4.59 | 2.89 |
Gross Profit | 3.50 | 3.80 | 5.23 | 4.31 | 2.96 |
SG&A, R&D, and Dept/Amort Expenses | 8.57 | 9.27 | 9.13 | 8.93 | 11.66 |
Income After SG&A, R&D, and Dept/Amort Expenses | -5.07 | -5.47 | -3.90 | -4.62 | -8.70 |
Non-Operating Income | 5.43 | -3.56 | 0.21 | -1.58 | -1.05 |
Interest Expense | 0.60 | 1.41 | 0.21 | 0.14 | 0.08 |
Pretax Income | -0.24 | -10.44 | 3.52 | -6.34 | -9.82 |
Income Taxes | 0.02 | 0.00 | -0.01 | 0.00 | 0.01 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -0.26 | -10.44 | 3.53 | -6.34 | -9.84 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -0.26 | -10.44 | 3.53 | -6.34 | -9.84 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 5.09 | 3.62 | 2.14 | 1.37 | 1.36 |
Diluted EPS Before Non-Recurring Items | -1.12 | -1.85 | -2.33 | -4.64 | -6.14 |
Diluted Net EPS (GAAP) | -0.05 | -2.88 | 4.45 | -4.64 | -7.23 |